Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis. Read more about Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
Co-infection of long-term carriers of Plasmodium falciparum with Schistosoma haematobium enhances protection from febrile malaria: a prospective cohort study in Mali. Read more about Co-infection of long-term carriers of Plasmodium falciparum with Schistosoma haematobium enhances protection from febrile malaria: a prospective cohort study in Mali.
Empiric deworming and CD4 count recovery in HIV-infected Ugandans initiating antiretroviral therapy. Read more about Empiric deworming and CD4 count recovery in HIV-infected Ugandans initiating antiretroviral therapy.
The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. Read more about The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases.
Dissecting the active site of the collagenolytic cathepsin L3 protease of the invasive stage of Fasciola hepatica. Read more about Dissecting the active site of the collagenolytic cathepsin L3 protease of the invasive stage of Fasciola hepatica.
Diverse inhibitor chemotypes targeting Trypanosoma cruzi CYP51. Read more about Diverse inhibitor chemotypes targeting Trypanosoma cruzi CYP51.
Investigation of the proteolytic functions of an expanded cercarial elastase gene family in Schistosoma mansoni. Read more about Investigation of the proteolytic functions of an expanded cercarial elastase gene family in Schistosoma mansoni.
A screen against Leishmania intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit. Read more about A screen against Leishmania intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit.
Mining a cathepsin inhibitor library for new antiparasitic drug leads. Read more about Mining a cathepsin inhibitor library for new antiparasitic drug leads.
Identification of small molecule lead compounds for visceral leishmaniasis using a novel ex vivo splenic explant model system. Read more about Identification of small molecule lead compounds for visceral leishmaniasis using a novel ex vivo splenic explant model system.
